This study will investigate whether reducing blood pressure can stop bleeding in the brain after thrombolysis (a clot-busting treatment for stroke) and improve patient's outcomes.
Exploring the effects of lowering blood pressure and a lower dose of clot busting drug on stroke outcome
This study will show whether more intensive lowering of blood pressure (BP) in survivors of intracerebral haemorrhage (ICH) is feasible, safe and effective in reducing brain injury. If successful, the study will pave the way for the design a larger definitive trial.
Some people can’t have their blood pressure measured in their arm. This project will use data that has been collected through previous research studies to investigate the relationship between blood pressure measured in the arm and leg, and the risk of stroke.
High blood pressure is one of the biggest risk factors for stroke. It is a contributing factor in around half of all strokes.
High blood pressure is the biggest risk factor for stroke. In the UK, 9.5 million people are diagnosed with high blood pressure, with a further 5.5 million cases undiagnosed. This guide explains the link between high blood pressure and stroke, the medication used to treat it and some steps you can take to lower your blood pressure.
This research is focused on assessing the relationship between the variability of the blood flow through the blood vessels supplying the brain, and the risk of stroke in patients who have already had a stroke or “mini-stroke” (TIA) in the past.
Video interview highlights from ten key trials that presented at ESOC 2016.
During February and March pharmacies across Wales are joining the Lower Your Risk of Stroke campaign, a partnership between Community Pharmacy Wales, Public Health Wales and the Stroke Association.
Over 3500 delegates attended the 2nd European Stroke Organisation Conference (ESOC 2016) today in Barcelona. Today’s program included teaching courses, scientific presentations, an official welcome from the ESOC President Professor Kennedy Lees and from Professor Angel Chamorro, and presentations from major clinical trials.